Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland. [electronic resource]
Producer: 20190403Description: 950-959 p. digitalISSN:- 1365-3156
- Adult
- Anti-Retroviral Agents -- economics
- Breast Feeding
- Cost-Benefit Analysis -- economics
- Eswatini
- Female
- HIV Infections -- drug therapy
- Humans
- Infectious Disease Transmission, Vertical -- prevention & control
- Mothers
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.